|
1
|
Barzaman K, Karami J, Zarei Z,
Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, Safari E and
Farahmand L: Breast cancer: Biology, biomarkers, and treatments.
Int Immunopharmacol. 84(106535)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Xu W, Zhang T, Zhu Z and Yang Y: The
association between immune cells and breast cancer: Insights from
Mendelian randomization and meta-analysis. Int J Surg. 111:230–241.
2025.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nafissi N, Saghafinia M, Motamedi MH and
Akbari ME: A survey of breast cancer knowledge and attitude in
Iranian women. J Cancer Res Ther. 8:46–49. 2012.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lüönd F, Tiede S and Christofori G: Breast
cancer as an example of tumour heterogeneity and tumour cell
plasticity during malignant progression. Br J Cancer. 125:164–175.
2021.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Onkar SS, Carleton NM, Lucas PC, Bruno TC,
Lee AV, Vignali DAA and Oesterreich S: The great immune escape:
Understanding the divergent immune response in breast cancer
subtypes. Cancer Discov. 13:23–40. 2023.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Li JJ, Tsang JY and Tse GM: Tumor
microenvironment in breast cancer-updates on therapeutic
implications and pathologic assessment. Cancers (Basel).
13(4233)2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zhao H, Yin X and Wang L, Liu K, Liu W, Bo
L and Wang L: Identifying tumour microenvironment-related signature
that correlates with prognosis and immunotherapy response in breast
cancer. Sci Data. 10(119)2023.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bergman PJ: Cancer immunotherapy. Vet Clin
North Am Small Anim Pract. 54:441–468. 2024.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Esteva FJ, Hubbard-Lucey VM, Tang J and
Pusztai L: Immunotherapy and targeted therapy combinations in
metastatic breast cancer. Lancet Oncol. 20:e175–e186.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lu Y, Wang X, Gu Q, Wang J, Sui Y, Wu J
and Feng J: Heterogeneous nuclear ribonucleoprotein A/B: An
emerging group of cancer biomarkers and therapeutic targets. Cell
Death Discov. 8(337)2022.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Geuens T, Bouhy D and Timmerman V: The
hnRNP family: Insights into their role in health and disease. Hum
Genet. 135:851–867. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Sudhakaran M and Doseff AI: Role of
heterogeneous nuclear ribonucleoproteins in the cancer-immune
landscape. Int J Mol Sci. 24(5086)2023.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Neriec N and Percipalle P: Sorting mRNA
molecules for cytoplasmic transport and localization. Front Genet.
9(510)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Thibault PA, Ganesan A, Kalyaanamoorthy S,
Clarke JWE, Salapa HE and Levin MC: hnRNP A/B Proteins: An
encyclopedic assessment of their roles in homeostasis and disease.
Biology (Basel). 10(712)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zhou ZJ, Dai Z, Zhou SL, Hu ZQ, Chen Q,
Zhao YM, Shi YH, Gao Q, Wu WZ, Qiu SJ, et al: HNRNPAB induces
epithelial-mesenchymal transition and promotes metastasis of
hepatocellular carcinoma by transcriptionally activating SNAIL.
Cancer Res. 74:2750–2762. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Pan T, Yu Z, Jin Z, Wu X, Wu A, Hou J,
Chang X, Fan Z, Li J, Yu B, et al: Tumor suppressor lnc-CTSLP4
inhibits EMT and metastasis of gastric cancer by attenuating
HNRNPAB-dependent Snail transcription. Mol Ther Nucleic Acids.
23:1288–1303. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhou J, Chen S, Liu J, Du J and Li J:
Knockdown of hnRNPAB reduces the stem cell properties and enhances
the chemosensitivity of human colorectal cancer stem cells. Oncol
Rep. 49(129)2023.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: . Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Blum A, Wang P and Zenklusen JC: SnapShot:
TCGA-Analyzed tumors. Cell. 173(530)2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
GTEx Consortium: The genotype-tissue
expression (GTEx) project. Nat Genet. 45:580–585. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Tang Z, Kang B, Li C, Chen T and Zhang Z:
GEPIA2: An enhanced web server for large-scale expression profiling
and interactive analysis. Nucleic Acids Res. 47(W1):W556–W560.
2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhao P, Zhen H, Zhao H, Huang Y and Cao B:
Identification of hub genes and potential molecular mechanisms
related to radiotherapy sensitivity in rectal cancer based on
multiple datasets. J Transl Med. 21(176)2023.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Ranstam J and Cook JA: Kaplan-Meier curve.
Br J Surg. 104(442)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Cerami E, Gao J, Dogrusoz U, Gross BE,
Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, et
al: The cBio cancer genomics portal: an open platform for exploring
multidimensional cancer genomics data. Cancer Discov. 2:401–404.
2012.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Tsujimoto H and Osafune K: Current status
and future directions of clinical applications using iPS
cells-focus on Japan. FEBS J. 289:7274–7291. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sepulveda JL: Using R and bioconductor in
clinical genomics and transcriptomics. J Mol Diagn. 22:3–20.
2020.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Chen L, Zhang YH, Wang S, Zhang Y, Huang T
and Cai YD: Prediction and analysis of essential genes using the
enrichments of gene ontology and KEGG pathways. PLoS One.
12(e0184129)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wu B, Fu L, Guo X, Hu H, Li Y, Shi Y,
Zhang Y, Han S, Lv C and Tian Y: Multi-omics profiling and digital
image analysis reveal the potential prognostic and
immunotherapeutic properties of CD93 in stomach adenocarcinoma.
Front Immunol. 14(984816)2023.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Rappsilber J, Mann M and Ishihama Y:
Protocol for micro-purification, enrichment, pre-fractionation and
storage of peptides for proteomics using StageTips. Nat Protoc.
2:1896–1906. 2007.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Lei L, Bai YH, Jiang HY, He T, Li M and
Wang JP: A bioinformatics analysis of the contribution of m6A
methylation to the occurrence of diabetes mellitus. Endocr Connect.
10:1253–1265. 2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhao X, Zhang L, Wang J, Zhang M, Song Z,
Ni B and You Y: Identification of key biomarkers and immune
infiltration in systemic lupus erythematosus by integrated
bioinformatics analysis. J Transl Med. 19(35)2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Huang R, Liao X and Li Q: Identification
of key pathways and genes in TP53 mutation acute myeloid leukemia:
Evidence from bioinformatics analysis. Onco Targets Ther.
11:163–173. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yang Y, Chen Q, Piao HY, Wang B, Zhu GQ,
Chen EB, Xiao K, Zhou ZJ, Shi GM, Shi YH, et al: HNRNPAB-regulated
lncRNA-ELF209 inhibits the malignancy of hepatocellular carcinoma.
Int J Cancer. 146:169–180. 2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xu C, Li B, Yu N, Yao B, Wang F and Mei Y:
The c-Myc targeting hnRNPAB promotes lung adenocarcinoma cell
proliferation via stabilization of CDK4 mRNA. Int J Biochem Cell
Biol. 156(106372)2023.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xin R, Shen B, Jiang YJ, Liu JB, Li S, Hou
LK, Wu W, Jia CY, Wu CY, Fu D, et al: Comprehensive analysis to
identify a novel PTEN-associated ceRNA regulatory network as a
prognostic biomarker for lung adenocarcinoma. Front Oncol.
12(923026)2022.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Han SP, Tang YH and Smith R: Functional
diversity of the hnRNPs: Past, present and perspectives. Biochem J.
430:379–392. 2010.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Carpenter B, MacKay C, Alnabulsi A, MacKay
M, Telfer C, Melvin WT and Murray GI: The roles of heterogeneous
nuclear ribonucleoproteins in tumour development and progression.
Biochim Biophys Acta. 1765:85–100. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Matta A, Tripathi SC, DeSouza LV, Grigull
J, Kaur J, Chauhan SS, Srivastava A, Thakar A, Shukla NK, Duggal R,
et al: Heterogeneous ribonucleoprotein K is a marker of oral
leukoplakia and correlates with poor prognosis of squamous cell
carcinoma. Int J Cancer. 125:1398–1406. 2009.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ma YL, Peng JY, Zhang P, Huang L, Liu WJ,
Shen TY, Chen HQ, Zhou YK, Zhang M, Chu ZX and Qin HL:
Heterogeneous nuclear ribonucleoprotein A1 is identified as a
potential biomarker for colorectal cancer based on differential
proteomics technology. J Proteome Res. 8:4525–4535. 2009.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Mikheev AM, Mikheev SA, Zhang Y, Aebersold
R and Zarbl H: CArG binding factor A (CBF-A) is involved in
transcriptional regulation of the rat Ha-ras promoter. Nucleic
Acids Res. 28:3762–3770. 2000.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Ramaswamy S, Ross KN, Lander ES and Golub
TR: A molecular signature of metastasis in primary solid tumors.
Nat Genet. 33:49–54. 2003.PubMed/NCBI View
Article : Google Scholar
|
|
42
|
Kuang X and Li J: Chromosome instability
and aneuploidy as context-dependent activators or inhibitors of
antitumor immunity. Front Immunol. 13(895961)2022.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Castellanos G, Camargo-Herrera LV, Rangel
N, Jiménez-Tobón GA, Martínez-Agüero M and Rondón-Lagos M:
Exploring chromosomal instability and clonal heterogeneity in
breast cancer. Endocr Relat Cancer. 31(e240096)2024.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Tauler J, Zudaire E, Liu H, Shih J and
Mulshine JL: hnRNP A2/B1 modulates epithelial-mesenchymal
transition in lung cancer cell lines. Cancer Res. 70:7137–7147.
2010.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Chen ZQ, Yuan T, Jiang H, Yang YY, Wang L,
Fu RM, Luo SQ, Zhang T, Wu ZY and Wen KM: MicroRNA-8063 targets
heterogeneous nuclear ribonucleoprotein AB to inhibit the
self-renewal of colorectal cancer stem cells via the Wnt/β-catenin
pathway. Oncol Rep. 46(219)2021.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Glaviano A, Singh SK, Lee EHC, Okina E,
Lam HY, Carbone D, Reddy EP, O'Connor MJ, Koff A, Singh G, et al:
Cell cycle dysregulation in cancer. Pharmacol Rev.
77(100030)2025.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Li F, Xie W, Fang Y, Xie K, Liu W, Hou L
and Tan W: HnRNP-F promotes the proliferation of bladder cancer
cells mediated by PI3K/AKT/FOXO1. J Cancer. 12:281–291.
2021.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Shi X, Ran L, Liu Y, Zhong SH, Zhou PP,
Liao MX and Fang W: Knockdown of hnRNP A2/B1 inhibits cell
proliferation, invasion and cell cycle triggering apoptosis in
cervical cancer via PI3K/AKT signaling pathway. Oncol Rep.
39:939–950. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Passacantilli I, Frisone P, De Paola E,
Fidaleo M and Paronetto MP: hnRNPM guides an alternative splicing
program in response to inhibition of the PI3K/AKT/mTOR pathway in
Ewing sarcoma cells. Nucleic Acids Res. 45:12270–12284.
2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Guo JN, Chen D, Deng SH, Huang JR, Song
JX, Li XY, Cui BB and Liu YL: Identification and quantification of
immune infiltration landscape on therapy and prognosis in left- and
right-sided colon cancer. Cancer Immunol Immunother. 71:1313–1330.
2022.PubMed/NCBI View Article : Google Scholar
|
